• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Health In Tech Announces Second Quarter 2025 Financial Results

    7/21/25 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance
    Get the next $HIT alert in real time by email
    • Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.
    • Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2 times full year 2024.
    • Cash balance of $8.1 million.

    STUART, Fla.  , July 21, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the second quarter ended June 30, 2025.

    HIT logo (PRNewsfoto/Health In Tech)

    Financial Highlights for the Second Quarter and First-Half of 2025: 

    • Revenues. Total revenues were $9.3 million, up 86% YoY. The first-half year revenues of $17.3 million, 89% of FY2024 total.
    • Billed Enrolled Employees. The number of billed enrolled employees (EEs) was 24,839, an increase of 5,738 EEs YoY.
    • Distribution. The number of Brokers, Third-party Administrator ("TPAs") and Agencies expanded to 778 partners, up 87% YoY.
    • Pre-tax income. Pre-tax income was $0.8 million, more than doubled YoY; The first-half year pre-tax income of $1.5 million, 1.7x of FY2024.
    • Adjusted EBITDA. Adjusted EBITDA was $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2x of FY2024.
    • Cash. Cash balance was $8.1 million as of June 30, 2025.
    • Accounts receivable, net. Accounts receivable balance was $1.3 million as of June 30, 2025, reduced $0.2 million YoY.

    "We delivered another strong quarter of profitable growth, with total revenue reaching $9.3 million—up 86% year over year—and first-half revenues already at 89% of our full-year 2024 total," said Tim Johnson, CEO of Health In Tech. "Our distribution network has expanded to 778 partners—an 87% increase year over year—reflecting our strategic focus on growing beyond traditional broker channels. We've established partnerships with TPAs offering technology-driven solutions, regional healthcare benefit providers, and service platforms that support small businesses. This approach is broadening our market reach and delivering greater value to our customers. The 30% increase in billed enrolled employees and strong adoption across our network underscore the demand for our differentiated services and offering."

    Mr. Johnson added, "What's particularly exciting is that many of our partners are now using our platform to bundle healthcare insurance with their existing services, enabling them to serve small business employer better by offering integrated, end-to-end solutions. Our AI-powered platform is easy to implement and highly intuitive, making it an ideal tool for partners seeking efficiency and scalability. With a broader distribution footprint and multiple new relationships in place, we're confident in our ability to maintain strong growth momentum through the rest of the year."

    "We're pleased with our second quarter results, which reflect strong execution and disciplined financial management across the business," said Julia Qian, CFO of Health In Tech. "Q2 revenue reached $9.3 million, bringing first-half revenue to $17.3 million—already 89% of our full-year 2024 total—driven by continued strategic expansion of our distribution network and strong customer acquisition. Adjusted EBITDA for the quarter was $1.6 million, up 134% year over year, with first-half adjusted EBITDA reaching $2.8 million—1.2 times our full-year 2024 result. First-half pretax income represented 8.8% of revenue, a nearly 300 basis point improvement year over year, demonstrating our ability to maintain expense discipline and allocate resources effectively to drive top-line growth. Supported by a solid $8.1 million cash position, we remain focused on investing in high-impact initiatives and advanced technology solutions that scale efficiently and sustain profitable growth.".

    Recent Business Developments and Highlights

    • Verdegard Administrators: an integrated, concierge-level TPA, owned by MedImpact, the largest independent pharmacy benefit manager (PBM) in the U.S., managing prescription benefits for over 20 million members and processing tens of billions in annual drug transactions. This partnership will enable us to reduce costs for small businesses.



    • Unified Health Plans: a premier TPA recognized for its extensive provider network across Kansas. It has extensive provider network and focuses on controlling cost drivers and improving care quality. Unified dominates several niche business sectors in Kansas. The partnership with HIT will bring healthcare insurance solutions to the business members.



    • HILB Group, one of Insurance Journal's Top 25 ranked U.S. insurance brokers with over 2400 employee across more than 125+ branch locations in all 50 States. It partners with HIT to co-develop and distribute smarter, more transparent self-funded health benefit solutions to a much broader base of small and mid-size employers.



    • Baily Insurance, established in 1880, in its fourth -generation ownership. The agency has over 200 years of combined team experience. Licensed advisors partnering with multiple Carriers. Baily is a co-founder and key broker partner in Fusion Health Plans that provides better care services and tech-enabled solution. The collaboration with HIT will deliver faster underwriting, administration, and scalability.

    Conference Call Details

    Health In Tech will host a conference call to discuss the financial results for the second quarter of 2025 on July 21, 2025, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).

    A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

    Non-GAAP Financial Information

    This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

    Use of Forward–Looking Statements

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

    About Health In Tech 

    Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

     

     

    Health In Tech, Inc.

    Consolidated Statements of Operations

    (Unaudited)







    Three Months Ended

    June 30,

    Six Months Ended

     June 30,







    2025



    2024



    2025



    2024



    Revenues





















    Revenues from underwriting modeling (ICE)



    $2,090,576



    $1,639,105



    $4,442,560



    $3,423,740





    Revenues from fees



    7,223,273



    3,363,385



    12,886,273



    6,703,681





        SMR



    7,223,273



    2,595,545



    12,886,273



    5,128,467





        HI Card



    -



    767,840



    -



    1,575,214





    Total revenues



    9,313,849



    5,002,490



    17,328,833



    10,127,421





    Cost of revenues



    3,003,979



    974,727



    5,663,564



    1,964,638





    Gross profit



    6,309,870



    4,027,763



    11,665,269



    8,162,783





    Operating expenses





















    Sales and marketing expenses



    1,226,738



    974,522



    2,316,993



    2,017,730





    General and administrative expenses        



    3,775,453



    1,816,679



    7,022,218



    3,815,873





    Research and development expenses



    582,609



    701,626



    1,120,330



    1,461,822





    Total operating expenses



    5,584,800



    3,492,827



    10,459,541



    7,295,425





    Other income (expense):





















    Interest income



    108,198



    31,339



    193,564



    55,651





    Interest expenses



    -



    (165,000)



    -



    (330,000)





    Other income



    -



    -



    118,399



    -





    Total other income (expense), net



    108,198



    (133,661)



    311,963



    (274,349)





    Income before income tax expense



    $833,268



    $401,275



    $1,517,691



    $593,009





    Provision for income taxes



    (202,637)



    (63,268)



    (388,468)



    (154,466)





    Net income



    $630,631



    $338,007



    $1,129,223



    $438,543





    Net income per share





















        Basic



    $0.01



    $0.01



    $0.02



    $0.01





        Diluted



    $0.01



    $0.01



    $0.02



    $0.01





    Weighted average common stocks outstanding                                  





















        Basic



    55,382,395



    51,769,358



    55,003,233



    51,769,358





        Diluted



    55,632,357



    51,769,358



    57,004,070



    51,769,358





     

     

    Health In Tech, Inc.

    Consolidated Balance Sheets

    (Unaudited)







    June 30, 2025



    December 31, 2024



    Assets 













    Current assets













    Cash



    $8,138,166



    $7,849,248





      Accounts receivable, net



    1,281,131



    1,647,103





      Other receivables



    3,854,834



    500,252





      Deferred offering costs



    66,500



    -





      Prepaid expenses and other current assets



    1,513,017



    787,161





    Total current assets



    14,853,648



    10,783,764





    Non-current assets













     Software



    5,519,110



    3,962,461





     Loans receivable, net



    847,993



    815,995





     Operating lease - right of use assets



    173,896



    206,269





      Long-term prepaid expenses



    783,603



    -





    Total non-current assets



    7,324,602



    4,984,725





    Total assets



    $22,178,250



    $15,768,489





    Liabilities and stockholders' equity













    Current liabilities













    Accounts payable and accrued expenses



    $4,327,475



    $1,858,840





    Income taxes payable



    34,944



    205,253





    Operating lease liabilities - current



    71,418



    66,881





       Other current liabilities



    955,743



    -





    Total current liabilities



    5,389,580



    2,130,974





    Non-current liabilities













    Deferred tax liabilities



    262,129



    328,676





    Operating lease liabilities - non-current



    102,938



    139,811





    Total non-current liabilities



    365,067



    468,487





    Total liabilities



    5,754,647



    2,599,461





    Stockholders' equity













    Common stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized, 44,679,664

      and 42,914,870 shares issued and outstanding as of June 30, 2025 and December 31, 2024,

      respectively



    44,679



    42,915





    Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000

      shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively



    11,700



    11,700





    Additional paid-in capital



    11,296,605



    9,173,017





    Retained earnings



    5,070,619



    3,941,396





    Total stockholders' equity



    16,423,603



    13,169,028





    Total liabilities and stockholders' equity



    $  22,178,250



    $15,768,489





     

     

    Health In Tech, Inc.

    Consolidated Statements of Cash Flows

    (Unaudited)







    Three Months Ended

    June 30,



    Six Months Ended

    June 30,







    2025



    2024



    2025



    2024



    CASH FLOWS FROM OPERATING ACTIVITIES:





















    Net income



    $630,631



    $338,007



    $1,129,223



    $438,543





    Adjustments to reconcile net income to net cash provided by operating activities:





















         Write-off of accounts receivable



    5,990



    -



    5,990



    -





         Amortization expense



    135,983



    134,787



    271,966



    269,574





         Provision for refund liability



    175,698



    -



    955,743



    -





         Deferred tax expenses (benefits)



    (32,074)



    754



    (66,547)



    (59,316)





         Amortization of debt discount



    -



    165,000



    -



    330,000





        Interest income



    (15,999)



    (15,999)



    (31,998)



    (31,998)





        Stock-based compensation expense



    707,963



    -



    1,201,134



    -





        Changes in operating assets and liabilities:





















                 Accounts receivable, net



    823,480



    556,793



    359,982



    777,895





                 Other receivables



    134,954



    382,279



    (3,354,582)



    619,372





                 Prepaid expenses and other current assets



    813,510



    (1,737)



    (204,241)



    (91,725)





                 Long-term prepaid expenses



    (357,666)



    -



    (357,666)



    -





                 Operating lease right of use assets and liabilities, net



    18



    623



    37



    1,247





                 Accounts payable and accrued expenses



    (1,150,600)



    (70,229)



    2,269,897



    (1,555,558)





                 Income taxes payable



    (390,612)



    (223,737)



    (170,309)



    (111,705)





    Net cash provided by operating activities



    1,481,276



    1,266,541



    2,008,629



    586,329





    CASH FLOWS FROM INVESTING ACTIVITIES:





















    Development of software



    (909,897)



    (93,962)



    (1,613,372)



    (227,356)





    Net cash used in investing activities



    (909,897)



    (93,962)



    (1,613,372)



    (227,356)





    CASH FLOWS FROM FINANCING ACTIVITIES:





















    Payments of deferred offering costs



    (8,250)



    (368,910)



    (106,339)



    (612,120)





    Net cash used in financing activities



    (8,250)



    (368,910)



    (106,339)



    (612,120)





    Increase (decrease) in cash



    563,129



    803,669



    288,918



    (253,147)





    Cash, beginning of the period



    7,575,037



    1,359,534



    7,849,248



    2,416,350





    Cash, end of the period



    8,138,166



    2,163,203



    8,138,166



    2,163,203





    Supplemental disclosures of cash flow information:





















    Cash paid for interest



    $-



    $-



    $-



    $-





    Cash paid for income taxes



    $625,323



    $286,252



    $625,323



    $325,487





    Summary of noncash investing and financing activities:





















    Accrued deferred offering costs included in accounts payable and accrued expenses



    $-



    $220,961



    $-



    $220,961





    Accrued development of software included in accounts payable and accrued expenses



    $265,243



    $25,817



    $265,243



    $25,817





    Issuance of Class A common stock for service 



    $1,037,984



    $-



    $1,037,984



    $-





























     

    Adjusted EBITDA Reconciliation

    (Unaudited)







    For Three Months Ended June 30,



    For Six Months Ended June 30,





    2024



    2025



    2024



    2025

    Net income



    $ 338,007



    $ 630,631



    $438,543



    $1,129,223

    Interest (income) expenses



    133,661



    (108,198)



    274,349



    (193,564)

    Depreciation and amortization



    134,787



    135,983



    269,574



    271,966

    Income tax expense



    63,268



    202,637



    154,466



    388,468

    Stock-based compensation expense



    -



    707,963



    -



    1,201,134

    Total net adjustments



    331,716



    938,385



    698,389



    1,668,004

    Adjusted EBITDA



    $ 669,723



    $1,569,016



    $1,136,932



    $2,797,227

     

    Components of Operating Results

    Revenues

    While we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries. Program services provided by SMR and MGU activities provided by ICE (including eDIYBS) are interdependent, as they cannot function effectively without being combined. Services provided by HI Card are an optional add-on to our other services, and cannot be offered on a standalone basis. Brokers that utilize the program services on behalf of the small employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service.

    Cost of revenues

    Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform. We mainly outsource captive management services and data services from the third-party companies. Our internal proprietary system seeks to consistently improve underwriting and services results through machine learning and data feeds. The captive management activities include introducing new carriers, conducting due diligence on carriers, conducting feasibility studies to determine the viability to be a stop-loss carrier on the platform, negotiating terms and contracts, coordinating audit requests, managing relationship with unrelated carriers and their regulators and auditor firms to ensure that our risk associated with our service offerings is minimized.

    Sales and marketing expenses

    Sales and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and commissions cost for our sales and marketing personnel. Sales and marketing expenses also include the costs for advertising, promotional and other marketing activities, as well as certain fees paid to various third-party for sales and customer acquisition.

    General and administrative expenses

    General and administrative expenses primarily consist of personnel-related costs and related expenses for our executives, finance, legal, human resources, technical support, and administrative personnel as well as the costs associated with professional fees for external legal, accounting and other consulting services, insurance premiums.

    Research and development expenses

    Research and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits for our research and development personnel. Additional expenses include costs related to the software development, quality assurance, and testing of new technology, and enhancement of our existing platform technology.

    Adjusted EBITDA

    Adjusted EBITDA represents our net income before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP. We exclude certain non-recurring or non-cash items when calculating Adjusted EBITDA, and we believe this approach provides a more meaningful measure by offering a clearer view of our underlying operational performance.

    Financial Results Summary

    (Unaudited)

    ($ in millions)





    Three Months Ended June 30,



    Six Months Ended June 30,





    2025





    2024



    % Change





    2025





    2024



    % Change

    Total revenues

    $

    9.3



    $

    5.0



    86.2 %



    $

    17.3



    $

    10.1



    71.1 %

    GAAP gross margin



    67.7 %





    80.5 %



    -12.8 %



    $

    67.3 %



    $

    80.6 %



    -13.3 %

    Income before income

       tax expense

    $

    0.8



    $

    0.4



    107.7 %



    $

    1.5



    $

    0.6



    155.9 %

    Adjusted EBITDA

    $

    1.6



    $

    0.7



    134.3 %



    $

    2.8



    $

    1.1



    146.0 %

     

     

    Investor Contact

    Investor Relations:

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-second-quarter-2025-financial-results-302509811.html

    SOURCE Health In Tech

    Get the next $HIT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HIT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HIT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Howard William D. was granted 128,474 shares (SEC Form 4)

      4 - Health In Tech, Inc. (0002019505) (Issuer)

      6/25/25 9:00:14 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Director Hayes Timothy was granted 128,474 shares (SEC Form 4)

      4 - Health In Tech, Inc. (0002019505) (Issuer)

      6/25/25 9:00:07 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Director Umemezia Chike was granted 128,474 shares (SEC Form 4)

      4 - Health In Tech, Inc. (0002019505) (Issuer)

      6/25/25 9:00:04 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Health In Tech Regains Compliance with Nasdaq's Minimum Bid Price Requirement

      STUART, Fla., July 24, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that it received formal written confirmation from The Nasdaq Stock Market, LLC ("Nasdaq") confirming that the Company has regained compliance with Nasdaq's minimum bid price requirement. To regain compliance with the Minimum Bid Price Requirement, the Company's common shares were required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive business days.  The closing bid price of the Shares

      7/24/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Partners with Verdegard Administrators to Elevate TPA Services Through eDIYBS

      STUART, Fla., July 24, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce a new collaboration with Verdegard Administrators, a licensed third-party administrator (TPA) based in Arizona. Together, the two companies aim to redefine how TPAs support brokers and employer groups by leveraging Health In Tech's Enhanced Do It Yourself Benefit Systems (eDIYBS) platform. Third-party administrators like Verdegard play a crucial role in the self-funded health insurance market, handling vital services s

      7/24/25 4:00:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech to Host Independent InsurTech Summit in Davos During World Economic Forum Week 2026

      STUART, Fla., July 23, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce it will host an exclusive half-day Summit on January 20, 2026, from  11:30 a.m. to 4:30 p.m. (CET) at the prestigious Belvedere Hotel in Davos, Switzerland, alongside the week of the World Economic Forum (WEF) Annual Meeting. The World Economic Forum, held each January in Davos, is one of the world's most prestigious gatherings of global leaders from business, government, academia, and civil society. It serves as a uni

      7/23/25 9:15:00 AM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    SEC Filings

    See more
    • Health In Tech Inc. filed SEC Form 8-K: Leadership Update

      8-K - Health In Tech, Inc. (0002019505) (Filer)

      7/28/25 5:01:58 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Health In Tech, Inc. (0002019505) (Filer)

      7/21/25 5:00:47 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Health In Tech, Inc. (0002019505) (Filer)

      7/21/25 4:35:27 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Leadership Updates

    Live Leadership Updates

    See more
    • Health In Tech to Participate as Gold Sponsor at American Trust Investment Services National Conference 2025

      STUART, Fl., May 20, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that CEO Tim Johnson and CFO Julia Qian will represent the company as a Gold Sponsor at the American Trust Investment Services National Conference 2025, to be held June 16–18, 2025, at the Andaz Hotel in San Diego, California. Hosted by American Trust Investment Services, this exclusive event will bring together registered representatives, advisors, and preferred sponsors for an immersive three-day conference focused on busin

      5/20/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Appoints Former U.S. Ambassador Edward McMullen to Advisory Board

      STUART, Fla., April 30, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is proud to announce the appointment of Edward T. McMullen Jr., former U.S. Ambassador to Switzerland and Liechtenstein, as a member of its newly formed Advisory Board, effective immediately. Mr. McMullen brings decades of experience in diplomacy, public affairs, and strategic policy, enhancing the company's mission to revolutionize healthcare insurance infrastructure. "Health In Tech is honored to welcome Mr. McMullen to our Advisory Board," said Tim Johnson, Chairman & CEO of Health In Tech. "His deep expertise in public affairs, government relations

      4/30/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Announces Appointment of Sanjay Shrestha to Board of Directors

      STUART, Fla., April 10, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, is pleased to announce the appointment of a new independent director, Sanjay Shrestha, to the Company's Board of Directors (the "Board"). Mr. Shrestha will serve as a member of the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee of the Board. "We are pleased to welcome Sanjay Shrestha to our Board of Directors," said Tim Johnson, Chairman & CEO of Health In Tech. "Sanjay brings a wealth of exp

      4/10/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance

    $HIT
    Financials

    Live finance-specific insights

    See more
    • Health In Tech Announces Second Quarter 2025 Financial Results

      Revenues of $9.3 million, up 86% YoY; The first-half year revenues of $17.3 million, 89% of full year 2024.Adjusted EBITDA of $1.6 million, up 134% YoY; The first-half year adjusted EBITDA of $2.8 million, 1.2 times full year 2024.Cash balance of $8.1 million.STUART, Fla.  , July 21, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the second quarter ended June 30, 2025. Financial Highlights for the Second Quarter and First-Half of 2025:  Revenues. Total revenues were

      7/21/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech to Announce Second Quarter 2025 Financial Results on July 21, 2025

      STUART, Fla., July 14, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced that it will release financial results for the quarter ended June 30, 2025, following the close of market on Monday, July 21, 2025. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent development and business outlook. Event: Health In Tech's 2025 Second Quarter Earnings Conference CallWhen: Monday, July 21, 2025, at 5:00 p.m. ET Live Call: PARTICIPANT DIAL IN (TOLL

      7/14/25 1:00:00 PM ET
      $HIT
      Specialty Insurers
      Finance
    • Health In Tech Announces First Quarter 2025 Financial Results

      Revenues increased 56% over the first quarter 2024 to $8.0 million, reflecting strong market demandIncome before income taxes more than tripled to $0.7 million, up 257% over the first quarter 2024Cash position remained strong at $7.6 million as of March 31, 2025STUART, Fla., April 14, 2025 /PRNewswire/ -- Health In Tech (NASDAQ:HIT), an Insurtech platform company backed by third-party AI technology, today announced its financial results for the first quarter ended March 31, 2025. Financial Highlights for the First Quarter of 2025 The number of enrolled employees (EEs) billed w

      4/14/25 4:30:00 PM ET
      $HIT
      Specialty Insurers
      Finance